Skip to content

Clinical trials

Head and Neck Neoplasms trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Head and Neck Neoplasms Country / region: Australia Clear all

76 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20031
20052
20081
20091
20112
20121
20154
20164
20178
20183
20194
202010
20217
20225
20236
20245
20256
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed21
Recruiting16
Active, not recruiting16
Terminated16
Unknown status3
Withdrawn2
Not yet recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca4
GlaxoSmithKline3
Merck Sharp & Dohme LLC3
Peter MacCallum Cancer Centre, Australia3
University of Sydney3
ALX Oncology Inc.2
BeiGene2
Bicara Therapeutics2
Eli Lilly and Company2
Hoffmann-La Roche2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Head and Neck Neoplasms76
Squamous Cell Carcinoma of Head and Neck23
Carcinoma, Non-Small-Cell Lung22
Colorectal Neoplasms17
Neoplasms17
Lung Neoplasms15
Ovarian Neoplasms15
Breast Neoplasms14
Melanoma13
Pancreatic Neoplasms13

Trials

Showing 1 to 25 of 76. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.